CA2288964A1 - Novel administration of thrombopoietin - Google Patents

Novel administration of thrombopoietin Download PDF

Info

Publication number
CA2288964A1
CA2288964A1 CA002288964A CA2288964A CA2288964A1 CA 2288964 A1 CA2288964 A1 CA 2288964A1 CA 002288964 A CA002288964 A CA 002288964A CA 2288964 A CA2288964 A CA 2288964A CA 2288964 A1 CA2288964 A1 CA 2288964A1
Authority
CA
Canada
Prior art keywords
tpo
dose
administered
cells
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002288964A
Other languages
English (en)
French (fr)
Inventor
Robert L. Cohen
Dan L. Eaton
Andrew J.S. Jones
Dennie V. Jones
Michael F. Powell
Theresa D. Sweeney
G. Roger Thomas
Gerard Wagemaker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2288964A1 publication Critical patent/CA2288964A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/196—Thrombopoietin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
CA002288964A 1997-05-21 1998-05-21 Novel administration of thrombopoietin Abandoned CA2288964A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US85976797A 1997-05-21 1997-05-21
US1501698A 1998-01-28 1998-01-28
US09/015,016 1998-01-28
US08/859,767 1998-01-28
PCT/US1998/010475 WO1998052598A1 (en) 1997-05-21 1998-05-21 Novel administration of thrombopoietin

Publications (1)

Publication Number Publication Date
CA2288964A1 true CA2288964A1 (en) 1998-11-26

Family

ID=26686844

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002288964A Abandoned CA2288964A1 (en) 1997-05-21 1998-05-21 Novel administration of thrombopoietin

Country Status (5)

Country Link
EP (1) EP0983082A1 (ja)
JP (1) JP4562815B2 (ja)
AU (1) AU7589898A (ja)
CA (1) CA2288964A1 (ja)
WO (1) WO1998052598A1 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2361260A1 (en) * 1999-01-28 2000-08-03 Saroj Vadhan-Raj Methods for increasing circulating platelets for collection and cryopreservation using thrombopoietin compositions
DE19956156A1 (de) * 1999-11-23 2001-06-13 Univ Eberhard Karls Verfahren zur Aufbereitung eines Präparates von Thrombozyten und Thrombozytenpräparat
US6673580B2 (en) 2000-10-27 2004-01-06 Genentech, Inc. Identification and modification of immunodominant epitopes in polypeptides
SK287901B6 (sk) * 2000-11-06 2012-03-02 Pharma Mar, S. A. Use of Ecteinascidin 743 for preparation of medicament for effective antitumor treatment
AU2003271194A1 (en) * 2003-10-09 2005-04-21 Daewoong Co., Ltd. Process for purifying human thrombopoietin with high content of sialic acid
BRPI0517238B1 (pt) 2004-10-29 2021-11-09 Pharma Mar, S.A. Composições que compreendem ecteinascidina e um dissacarídeo, método para produzir um frasco que contém a referida composição e para preparar uma solução para infusão intravenosa e uso da referida solução
GB0522082D0 (en) 2005-10-31 2005-12-07 Pharma Mar Sa Formulations
EP3045123B1 (en) * 2008-06-16 2020-04-08 University Of Rochester Compositions comprising a combination of fibroblast growth factor (fgf) analogs with thrombopoietin for use for treating acute radiation syndrome
CA2761896A1 (en) * 2009-05-13 2010-11-18 The University Of North Carolina At Chapel Hill Cyclin dependent kinase inhibitors and methods of use
CN102481332A (zh) 2009-06-14 2012-05-30 拜欧肯疗法有限公司 用于提高血小板水平的肽疗法
DE102011085695A1 (de) * 2011-11-03 2013-05-08 Jörg Pohl Einmalig dosierte Oxazaphosphorine zur Therapie von Krankheiten
WO2013160895A1 (en) 2012-04-24 2013-10-31 Biokine Therapeutics Ltd. Peptides and use thereof in the treatment of large cell lung cancer
BR112018000903A2 (pt) 2015-07-16 2018-09-11 Biokine Therapeutics Ltd. composições e métodos para o tratamento de câncer
KR102033920B1 (ko) 2016-02-23 2019-10-18 바이오라인알엑스 리미티드 급성 골수성 백혈병을 치료하는 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2285446B (en) * 1994-01-03 1999-07-28 Genentech Inc Thrombopoietin
JP2991630B2 (ja) * 1994-02-14 1999-12-20 麒麟麦酒株式会社 ヒトｔｐｏ活性を有するタンパク質をコードするｄｎａ
CZ288926B6 (cs) * 1994-03-31 2001-09-12 Amgen Inc. MGDF derivát, způsob jeho výroby a farmaceutický prostředek s jeho obsahem
US5879673A (en) * 1996-01-25 1999-03-09 Genentech, Inc. Administration of thrombopoietin on a single day only

Also Published As

Publication number Publication date
WO1998052598A1 (en) 1998-11-26
EP0983082A1 (en) 2000-03-08
JP2001526689A (ja) 2001-12-18
JP4562815B2 (ja) 2010-10-13
AU7589898A (en) 1998-12-11

Similar Documents

Publication Publication Date Title
ES2314999T3 (es) Factor celular madre.
AU711639B2 (en) Novel administration of thrombopoietin
DE69934425T2 (de) Thrombopoietin substitute
CA2288964A1 (en) Novel administration of thrombopoietin
US6013067A (en) Methods for increasing hematopoietic cells
JP2002512006A (ja) ＴＮＦ受容体スーパーファミリーの一員である成熟ＦＬＩＮＴ（ｍＦＬＩＮＴ）ポリペプチド、または、ＯＰＧ３の治療上の適用
CA2212006A1 (en) Novel c-mpl ligands
CA2170979A1 (en) Increase in hematopoietic progenitor cells in peripheral blood by transforming growth factor beta
JP2003535144A (ja) 多能性造血幹細胞の流動を刺激するヒト成長ホルモン
JPH05509096A (ja) 骨髄間質細胞及び始原細胞の刺激
JP2853905B2 (ja) 未結合ｍｐｌ受容体を用いた血小板産生を刺激するための組成物
JPH05247095A (ja) 新規な巨核球増幅因子とその製造方法および医薬組成物
AU2006201129B2 (en) Novel administration of thrombopoietin
AU2019370284A1 (en) Combination therapy method of treating myeloproliferative neoplasms with a diphtheria toxin-human interleukin-3 conjugate in combination with other agents
US6403553B1 (en) Use of polypeptides for treating thrombocytopenia
EP1033997B1 (en) Method of mobilizing hematopoietic stem cells
JPH07118163A (ja) β２−ミクログロブリンを含有する組成物
MXPA97009244A (en) Methods to increase hematopoyeti cells
JPH05255396A (ja) ヒトインターロイキン１１様蛋白とその製造方法および医薬組成物

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead

Effective date: 20141015